Ying, Zhong, Wang, Irene, Bluemcke, Ingmar, Bulacio, Juan, Alexopoulos, Andreas, Jehi, Lara, Bingaman, William, Gonzalez-Martinez, Jorge, Kobow, Katja, Niestroj, Lisa Marie, Lal, Dennis, Koelble, Konrad and Najm, Imad (2019). A comprehensive clinico-pathological and genetic evaluation of bottom-of-sulcus focal cortical dysplasia in patients with difficult-to-localize focal epilepsy. Epileptic Disord., 21 (1). S. 65 - 78. MONTROUGE: JOHN LIBBEY EUROTEXT LTD. ISSN 1950-6945

Full text not available from this repository.

Abstract

Aims. We comprehensively studied the clinical presentation, stereo-EEG and MRI findings, histopathological diagnosis, and brain somatic mutations in a retrospective series of drug-resistant patients with difficult-to-localize epilepsy due to focal cortical dysplasia at the bottom of a sulcus (BOS-FCD).Methods. We identified 10 patients with BOS-FCD from the Cleveland Clinic epilepsy surgery database submitted for intracranial video-EEG monitoring. Brain MRI, including voxel-based morphometric analysis and surgical tissue submitted for histopathology, was reviewed. Paraffin tissue samples from five patients were made available for targeted next-generation sequencing. Postsurgical follow-up was available in nine patients.Results. BOS-FCD was identified in the superior frontal sulcus in six patients, inferior frontal sulcus in one patient, central sulcus in one patient, and intraparietal sulcus in two patients. All patients had stereotyped seizures. Intracranial EEG recordings identified ictal onset at the BOS-FCD in all 10 patients, whereas ictal scalp EEG had a localizing value in only six patients. Complete resection was achieved by lesionectomy or focal corticectomy in nine patients. Histopathologically, six patients had FCD type IIb and three had FCD type IIa. Next-generation sequencing analysis of DNA extracted from lesion-enriched (micro-dissected) tissue from five patients with FCD type II led to the identification of a germline frameshift insertion in DEPDC5, introducing a premature stop in one patient. Eight out of nine patients with available follow-up were completely seizure-free (Engel Class IA) after a mean follow-up period of six years.Conclusion. Our results confirm previous studies classifying difficult-to-localize BOS-FCD into the emerging spectrum of FCD ILAE type II mTORopathies. Further studies with large patient numbers and ultra-deep genetic testing may help to bridge the current knowledge gap in genetic aetiologies of FCD.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Ying, ZhongUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wang, IreneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bluemcke, IngmarUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bulacio, JuanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Alexopoulos, AndreasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Jehi, LaraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bingaman, WilliamUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gonzalez-Martinez, JorgeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kobow, KatjaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Niestroj, Lisa MarieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lal, DennisUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koelble, KonradUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Najm, ImadUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-157142
DOI: 10.1684/epd.2019.1028
Journal or Publication Title: Epileptic Disord.
Volume: 21
Number: 1
Page Range: S. 65 - 78
Date: 2019
Publisher: JOHN LIBBEY EUROTEXT LTD
Place of Publication: MONTROUGE
ISSN: 1950-6945
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
SOMATIC MUTATIONS; CONSENSUS CLASSIFICATION; DIAGNOSTIC METHODS; MAMMALIAN TARGET; MTOR PATHWAY; BRAIN-TISSUE; TASK-FORCE; MRI; VARIANTS; IMPROVESMultiple languages
Clinical NeurologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/15714

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item